President, Global Head of R&D · BeOne Medicines Ltd. · American Depositary Shares
Side
SELL
Value
$11K
Shares
40
Price
$270.73
Executed
Jun 8, 2026
Disclosed
Jun 10, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jun 8 executedJun 10, 2026 disclosed
ONC · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+15 / 15
3 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Wang Lai filed this Form 4 reporting a open-market sale of ONC on Jun 8, 2026. It became public on Jun 10, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
President, Global Head of R&D
Wang Laicik:0001852291
Issuer
BeOne Medicines Ltd.cik:0001651308
Revision history · 0
No field has changed since this record was first ingested.
